Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized double-blind study of omadacycline versus levofloxacin for acute pyelonephritis
2018-000037-13Phase 2Completed
- Sponsor
- Paratek Pharmaceuticals
- Start
- Jun 2018
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in acute pyelonephritis comparing Omadacycline with Levofloxacin (2 arms). Primary endpoint: Overall response at Post Therapy Evaluation. Started Jun 2018; status: completed.
02
Drugs
omadacyclinelevofloxacin
03
Conditions
acute pyelonephritis
Beyond the preview
Go deeper on 2018-000037-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000037-13.